Aspire Biopharma Hldgs (ASBP) Stock Price, Quote, News & History

Aspire Biopharma Holdings Inc (ASBP) Stock Price, Quote, News & History

ASBPNASDAQ

Trade with Public

At close: Mar 13, 5:00 PM EST

$1.10

-0.025-2.22%

After Hours: 9:22 AM EST

Key Statistics

Open

$1.11

Volume / Avg.

159.26K / 1.02M

Day Range

$1.04 - $1.16

52 Wk Range

1.11 - 35.01

Market Cap

$5.53M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.48%

Days to Cover

2.54

Recent Aspire Biopharma Holdings Inc News

PRO
Aspire Partners With Microsize To Create Quick-Dissolve Anxiety Drug

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted, patent-pending drug delivery technology, today announced a strategic partnership with

Benzinga Newsdesk

PRO
Aspire Biopharma Regains Nasdaq Listing Compliance

Benzinga Newsdesk

PRO
Aspire Biopharma Files provisional patent application With U.S. Patent and Trademark Office Titled 'A Sublingual Powder Formulation of Ondansetron and Methods of Use Thereof'

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a provisional patent

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.52M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

5.45M

Free Cash Flow (TTM)

-3.52M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.93M

Valuation Metrics

Enterprise Value

$12.33M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

717.63

PB Ratio (TTM)

Earnings Yield % (TTM)

-2280.57%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$2.28

Company Debt

Total Debt

$8.62M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.95M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.11

Volume / Avg.

159.26K / 1.02M

Day Range

$1.04 - $1.16

52 Wk Range

1.11 - 35.01

Market Cap

$5.53M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.48%

Days to Cover

2.54

About

Sector

Health Care

Industry

Pharmaceuticals

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aspire Biopharma Hldgs (ASBP) stock?

You can purchase shares of Aspire Biopharma Hldgs (NASDAQ:ASBP) through any online brokerage.

View our list of the best stock brokerages

Who are Aspire Biopharma Hldgs (ASBP) competitors?

Other companies in Aspire Biopharma Hldgs’s space includes: Iterum Therapeutics PLC (NASDAQ:ITRM), Gelteq Ltd (NASDAQ:GELS), 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), Kiora Pharmaceuticals Inc (NASDAQ:KPRX) and InMed Pharmaceuticals Inc (NASDAQ:INM).

What is the forecast, or price target, for Aspire Biopharma Hldgs (ASBP) stock?

There is no analysis for Aspire Biopharma Hldgs to provide a consensus price target.

What is the current price for Aspire Biopharma Hldgs (ASBP)?

The stock price for Aspire Biopharma Hldgs (NASDAQ: ASBP) is $1.1 last updated March 13, 2026 at 9:22 AM EDT.

Does Aspire Biopharma Hldgs (ASBP) pay a dividend?

There are no upcoming dividends for Aspire Biopharma Hldgs.

When is Aspire Biopharma Hldgs (NASDAQ:ASBP) reporting earnings?

Aspire Biopharma Hldgs does not have any upcoming earnings scheduled.

Is Aspire Biopharma Hldgs (ASBP) going to split?

There is no upcoming split for Aspire Biopharma Hldgs.

What sector and industry does Aspire Biopharma Hldgs (ASBP) operate in?

Aspire Biopharma Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Iterum Therapeutics PLC

60 Degrees Pharmaceuticals Inc

NASDAQ:SXTP

$2.45

-21.22%

Kiora Pharmaceuticals Inc

NASDAQ:KPRX

$2.20

5.00%

InMed Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc

NASDAQ:SNOA

$2.62

0.19%

Key Statistics

Open

$1.11

Volume / Avg.

159.26K / 1.02M

Day Range

$1.04 - $1.16

52 Wk Range

1.11 - 35.01

Market Cap

$5.53M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.48%

Days to Cover

2.54

Recent Aspire Biopharma Holdings Inc News

PRO
Aspire Partners With Microsize To Create Quick-Dissolve Anxiety Drug

Benzinga Newsdesk

PRO
Aspire Biopharma Regains Nasdaq Listing Compliance

Benzinga Newsdesk

PRO
Aspire Biopharma Files provisional patent application With U.S. Patent and Trademark Office Titled 'A Sublingual Powder Formulation of Ondansetron and Methods of Use Thereof'

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.52M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

5.45M

Free Cash Flow (TTM)

-3.52M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.93M

Valuation Metrics

Enterprise Value

$12.33M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

717.63

PB Ratio (TTM)

Earnings Yield % (TTM)

-2280.57%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$2.28

Company Debt

Total Debt

$8.62M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.95M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.11

Volume / Avg.

159.26K / 1.02M

Day Range

$1.04 - $1.16

52 Wk Range

1.11 - 35.01

Market Cap

$5.53M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.48%

Days to Cover

2.54

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry